Skip to Main Content

Author Details

Robert T Dess
University of Michigan ann arbor
2016
83
23
PMIDPaper TitleJournal TitlePublished Year
37924987Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled Trial.Int J Radiat Oncol Biol Phys2024
38049229A New Pos-SIB-ility for Prostate and Pelvic Nodal Radiation Therapy in High-Risk Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2024
35878714A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer.Int J Radiat Oncol Biol Phys2023
37851053Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption.World J Urol2023
37100388Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative.Pract Radiat Oncol2023
36754278Cardiac and Pulmonary Dosimetric Parameters in Patients With Lung Cancer Undergoing Postoperative Radiation Therapy Across a Statewide Consortium.Pract Radiat Oncol2023
36579470Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126.Cancer2023
36503624Validation of the Combination Gleason Score as an Independent Favorable Prognostic Factor in Prostate Cancer Treated With Dose-Escalated Radiation Therapy.Pract Radiat Oncol2023
36630135Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis.JAMA Netw Open2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
34285350Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborative.Prostate Cancer Prostatic Dis2022
35737923Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601.J Clin Oncol2022
35373440Development and validation of a life expectancy calculator for US patients with prostate cancer.BJU Int2022
35469702High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.Eur Urol2022
35427560Personalized Medicine in Localized Prostate Cancer: Are We There Yet?Int J Radiat Oncol Biol Phys2022
36279204Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities.JAMA Oncol2022
35121192Effect of Education and Standardization of Cardiac Dose Constraints on Heart Dose in Patients With Lung Cancer Receiving Definitive Radiation Therapy Across a Statewide Consortium.Pract Radiat Oncol2022
35271524Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer.Am J Clin Oncol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
35022600Clinicogenomic characterization of prostate cancer liver metastases.Prostate Cancer Prostatic Dis2022
35167337Racial Differences in Treatments and Toxicity in Patients With Non-Small-Cell Lung Cancer Treated With Thoracic Radiation Therapy.JCO Oncol Pract2022
34838865Association Between Physician- and Patient-Reported Symptoms in Patients Treated With Definitive Radiation Therapy for Locally Advanced Lung Cancer in a Statewide Consortium.Int J Radiat Oncol Biol Phys2022
31411981Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer.Eur Urol Oncol2021
33662287Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis.Lancet Oncol2021
33610267Particle Beam Therapy for Cardiac-Sparing Radiotherapy in Non-Small Cell Lung Cancer.Semin Radiat Oncol2021
34964855Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.JAMA Netw Open2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
34314815Predictors of Pneumonitis After Conventionally Fractionated Radiotherapy for Locally Advanced Lung Cancer.Int J Radiat Oncol Biol Phys2021
34089677Prostate Brachytherapy Boost: Where Are We and Where Are We Going.Int J Radiat Oncol Biol Phys2021
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
34086486End Point Definitions and Surrogacy in Prostate Cancer: Will Metastasis-Free Survival Become Event-Free Survival With Advances in Molecular Imaging?J Clin Oncol2021
34028551Olaparib vs Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer.JAMA Netw Open2021
33309278A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).Eur Urol2021
33276019Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate Cancer.Int J Radiat Oncol Biol Phys2021
33275486Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis.J Clin Oncol2021
31382026Cardiac Dose in Locally Advanced Lung Cancer: Results From a Statewide Consortium.Pract Radiat Oncol2020
35050780Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate.JCO Precis Oncol2020
31839379Why the UK Should Consider Gene Expression Testing in Prostate Cancer.Clin Oncol (R Coll Radiol)2020
31977386Clinically Lymph Node Positive Prostate Cancer: At the Intersection of Focal and Systemic Disease Control.Cancer J2020
32092344Treatment Intensification in High-Risk Prostate Cancer: Lessons From the TROG 03.04 RADAR Trial.Int J Radiat Oncol Biol Phys2020
33145460Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19.Adv Radiat Oncol2020
33090219Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.JAMA Oncol2020
33119036Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic.JAMA Oncol2020
32997578Reply to L. C. Mendez et al and M. A. Kollmeier et al.J Clin Oncol2020
32599760Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes.J Clin Med2020
32215583Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.JAMA Oncol2020
32231245Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier.Prostate Cancer Prostatic Dis2020
32292839Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19.Adv Radiat Oncol2020
32396488Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials.J Clin Oncol2020
  • 1 - 50 of 83

Recommended Authors

Audrey Dang
Tulane University School of Medicine
Career Start Year 2018
Number of shared co-authors 29
Ryan Phillips
Johns Hopkins University
Career Start Year 2017
Number of shared co-authors 26
Hilary P Bagshaw
Stanford University
Career Start Year 2014
Number of shared co-authors 34
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 4
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 8
Kiri A Sandler
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 44
Devin N Patel
university of california san diego School of Medicine
Career Start Year 2011
Number of shared co-authors 1
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 33
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 5
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 10
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 16
Alastair D Lamb
University of Oxford
Career Start Year 2007
Number of shared co-authors 13
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 29
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 17
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 4
Channing J Paller
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 21
Piet Ost
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 41
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 6
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 4
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 49
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 17
Mark K Buyyounouski
Stanford University
Career Start Year 1999
Number of shared co-authors 43
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 12
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 26
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 36
Laurence Collette
Belgium International Drug Development Institute
Career Start Year 1995
Number of shared co-authors 26
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 14
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 32
Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year 1993
Number of shared co-authors 22
Fred Saad
University of Montreal Health Center
Career Start Year 1990
Number of shared co-authors 33

Collaborators

Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 59
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 38
William C Jackson
University of Michigan ann arbor
Co-authored papers 35
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 23
Amar U Kishan
University of California los angeles
Co-authored papers 21
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 21
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 18
Brandon A Mahal
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 17
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 14
Thomas M Pisansky
Mayo Clinic
Co-authored papers 12
Holly E Hartman
Case Western Reserve University
Co-authored papers 10
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 9
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 9
Simpa S Salami
University of Michigan Medical School ann arbor
Co-authored papers 9
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 9
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 9
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 9
Michael L Steinberg
University of California los angeles
Co-authored papers 9
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 8
Bradley J Stish
Mayo Clinic
Co-authored papers 8
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 8
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 7
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 7
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 7
Brian J Davis
Mayo Clinic
Co-authored papers 7
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 7
Neil B Desai
University of Texas Southwestern Medical Center
Co-authored papers 6
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 6
Curtiland Deville
Johns Hopkins University
Co-authored papers 6
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 6
Release 1.2